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Summary
Introduction:  The  issue  of  prognosis  in  limb  length  discrepancy  in  children  affected  by  congeni-
tal abnormality  remains  a  subject  of  concern.  Therapeutic  strategy  must  take  length  prediction
into account,  to  adapt  equalization  techniques  and  the  timing  of  treatment.  Initial  prognosis,
however,  may  need  revising  after  completion  of  one  or  several  surgical  interventions  on  the
pathologic  limb.  The  aim  of  this  study  was  to  determine  the  different  types  of  growth  response
that a  bone  segment  can  present  after  progressive  lengthening  in  case  of  congenital  limb  length
discrepancy.
Materials  and  methods:  A  series  of  114  bone  lengthenings  with  external  ﬁxator,  performed  in  36
girls and  50  boys  with  congenital  lower  limb  length  discrepancy,  was  retrospectively  analyzed.
Bone segment  growth  rates  were  measured  before  lengthening,  during  the  ﬁrst  year  after  frame
removal and  ﬁnally  over  long-term  follow-up,  calculating  the  ratios  of  radiological  bone  length
to the  number  of  months  between  two  measurements.  Mean  follow-up  was  4.54  ±  0.2  years.
nd  long-term  growth  rate  distinguished  ﬁve  patterns  of  bone  behav-Results: Changes  in  short-  a
ior after  lengthening,  ranging  from  growth  acceleration  to  total  inhibition.
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Discussion:  These  ﬁve  residual  growth  patterns  depended  on  certain  factors  causing  accelera-
tion or,  on  the  contrary,  slowing  down  of  growth:  age  at  the  lengthening  operation,  percentage
lengthening,  and  minimal  period  between  two  lengthenings.  These  criteria  help  optimize  con-
ditions for  resumed  growth  after  progressive  segmental  lengthening,  avoiding  conditions  liable
to induce  slowing  down  or  inhibition,  and  providing  a  planning  aid  in  multi-step  lengthening
programs.
Level of  evidence:  Level  IV.  Retrospective  study.
© 2012  Published  by  Elsevier  Masson  SAS.
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•  R0  =  L1—L0/month:  growth  rate  before  lengthening;
• R1  =  L3—L2/month:  growth  rate  during  the  ﬁrst  year  after
EF  removal  (or  ‘‘short-term  growth  rate’’);
• R2  =  L4—L3/month,  ‘‘long-term  growth  rate’’,  following
the  ﬁrst  year  after  EF  removal.
Figure  1  Diagrammatic  presentation  of  residual  growth  gain
(RGG)  calculation,  taking  account  of  length  gain  (LG),  pre-
dicted ﬁnal  spontaneous  segmental  discrepancy  (PFSSD)  in  casentroduction
esidual  growth  after  progressive  lengthening  has  been  the
ocus  of  several  studies  [1—9], but  the  evolution  of  congen-
tal  lower-limb  length  discrepancy  in  children  undergoing
rogressive  lengthening  remains  unforeseeable  and  the  fac-
ors  relevant  to  bone  segment  activity  in  these  cases  remain
ndetermined.  Both  slowing  and  boosted  growth  patterns
ave  been  reported,  independently  of  the  lengthening  tech-
ique  (Judet,  Wagner,  Callotasis  or  Cauchoix)  employed
2—6], other  authors  ﬁnding  no  change  in  growth  rates
7—9].
The  present  retrospective  study  sought  to  identify  fac-
ors  affecting  residual  growth  after  progressive  lengthening:
ge  at  lengthening,  percentage  lengthening,  and  single-  or
ultistep  strategy.
aterial and methods
esidual  bone  segment  growth  after  progressive  length-
ning  was  studied  on  a  retrospective  design.  The  series
omprised  36  girls  and  50  boys,  with  a  mean  bone  age
f  8.5  ±  0.23  years  (range,  4.5  to  15  yrs)  at  ﬁrst  length-
ning  operation.  The  series  was  homogeneous  for  etiology
nd  surgical  procedure.  It  comprised  114  consecutive  single-
egment  lengthening  procedures  using  the  Ilizarov  technique
circular  ﬁxation,  percutaneous  osteotomy,  and  lengthening
nitiated  as  of  postoperative  day  5),  and  involved  59  femurs
nd  55  tibias  with  exclusively  congenital  etiology  [10,11].
ighty-seven  procedures  were  primary  and  24  iterative.
Mean  femoral  lengthening  was  4.8  ±  0.16  cm  (range,  2
o  8  cm;  i.e.,  19.7  ±  1.02%),  and  mean  tibial  lengthening
.9  ±  0.26  cm  (1.5  to  10  cm;  i.e.,  21.2  ±  0.62%).  Mean  con-
olidation  index  [12]  was  26.3  ±  1.22  days/cm  for  the  femur
nd  27.3  ±  1.94  days/cm  for  the  tibia.
Any  associated  axial  deformities  were  corrected  during
engthening,  to  ensure  a  normal  biomechanical  lower-limb
xis  in  all  cases.  The  knee  joint  was  bridged  in  case  of  clinical
oint  instability,  with  distraction  maintained  throughout  the
engthening  process.
The  external  ﬁxator  (EF)  was  removed  as  soon  as  con-
olidation  was  conﬁrmed  (homogenous  callous  formation,
omplete  disappearance  of  regenerate  growth  area,  and
ppearance  of  at  least  three  cortices)  on  X-ray.  Mean  follow-
p  after  ﬁxator  ablation  was  4.54  ±  0.2  years.
Segmental  growth  was  monitored  6-monthly  or  yearly
rom  1  year  before  to  at  least  2  years  after  length-
ning,  by  comparative  whole  lower-limb  X-ray  of  the
o
(
f
lengthened  and  contralateral  healthy  segments.  Bone  age
ccording  to  Greulich  and  Pyle  was  determined  once  a
ear.
Radiologic  length  (L),  growth  rate  (R)  and  change  in
rowth  rate  (C)  were  measured  as  follows:
Radiologic  length  (L)  of  each  healthy  and  lengthened  seg-
ent  (Fig.  1)  was  measured:
L0:  1  year  before  surgery;
L1:  immediately  before  surgery  (L1);
L2:  4  to  6  weeks  after  EF  removal;
L3:  7  to  12  months  after  EF  removal;
 L4:  greater  or  equal  to  2  years  after  EF  removal.
Growth  rate  (R,  in  mm/month)  was  determined  in  terms
f  differential  radiologic  length  for  a  given  segment:f no  lengthening  (mm),  ﬁnal  residual  segmental  discrepancy
FRSD)  (mm)  obtained  by  subtracting  healthy  segment  length
rom  lengthened  segment  length,  and  ﬁnal  lengthened  segment
ength  (FLSL).
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Table  1  Distribution  of  5  types  of  growth  patterna for  the  99  lengthening  procedures  with  both  short-  and  long-term  follow-up.
Parameters  AI  AII  AIII  BI  BII
Number  31  29  8  7  24
Age (yrs)  7.2  ±  0.299AII,  BII 8.5  ±  0.42BII 8.8  ±  1.1  7.2  ±  0.75BII 10.1  ±  0.53
Length gain  (cm)  4.8  ±  0.24  4.5  ±  0.35BI 4.4  ±  0.41BI 6.0  ±  0.58  5.1  ±  0.44
% length  gain  21.5  ±  1.78  17.5  ±  2.06BI 16.5  ±  2.3BI 31.5  ±  4.89  18.7  ±  2.5BI
First  lengthening  29  28  8  7  7
Iterative lengthening  2  1  0  0  17
Femoral HI 26.2  ±  1.68  24.4  ±  1.41  23.2  ±  2.11  26.9  28.3  ±  2.61
Tibial HI 24.5  ±  1.84 28.7  ±  5.10  28.5  ±  2.66  23.1  ±  2.56  30.1  ±  8.38
% RGG 2.6  ±  0.46  (7)AII,  AIII,  BII 0.8  ±  0.45  (12)AIII,  BII −1.9  ±  1.36  (3)BII — −3.7  ±  1.20  (14)
Knee bridge 12 7 3 2 17
1 0.55  ±  0.096AII,  AIII,  BI,  BII 0.27  ±  0.35BI,  BII 0.19  ±  0.07 BI,  BII −0.56  ±  0.07  −0.66  ±  0.057
2 0.31  ±  0.039AII,  AIII,  BII 0.02  ±  0.011AIII,  BI,  BII −0.39  ±  0.08BI,  BII 0.52  ±  0.167BII −0.59  ±  0.051
FU (yrs)  4.4  ±  0.44  4.5  ±  0.31  3.8  ±  0.69  3.8  ±  0.94  4.2  ±  0.42
In brackets (): number of patients, for certain parameters.
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•RGG: residual growth gain; HI: healing index (days/cm); 1: shor
a AII, AIII, BI, BII — signiﬁcant differences between these groups
Following  the  criteria  deﬁned  by  Suva  et  al.  [5],  a length
difference  of  2  mm  was  counted  as  a  change  in  growth  for
an  observation  period  of  at  least  3  months.
Change  in  growth  rate  ()  was  calculated  from  the  fol-
lowing  ratios:
1 = R1−R0R0 Short-term  growth-rate  change,  during  the
ﬁrst year  after  EF  removal
2 = R2−R0R0 Long-term  growth-rate  change,  following
the ﬁrst  year  after  EF  removal
Hechard-Carlioz  charts  [13]  were  used  for  monitoring
femoral  and  tibial  longitudinal  growth.  Preoperatively,  pre-
dicted  limb-length  discrepancy  and  ﬁnal  segment  length
were  assessed  using  the  multiplier  method  [14]  taking  into
account  that,  without  treatment,  the  natural  growth  of  a
malformed  segment  is  linear,  with  a  constant  rate,  so  that
change  in  percentage  discrepancy  will  likewise  be  linear
[15].
Residual  growth  was  studied  by  grouping  the  114  length-
ening  procedures  according  to  whether  the  growth  phase
was  ongoing  (group  1:  n  =  71)  or  bone  maturity  had
been  reached  (group  2:  n  =  43),  and  further  distinguishing
between  those  studied  over  both  the  short  and  the  long  term
(both  during  and  after  the  ﬁrst  year  after  external  ﬁxator
removal:  n  =  99)  and  those  studied  only  over  the  long  term
(at  least  1  year  after  external  ﬁxator  removal:  n  =  15).  The
latter  growth-rate  analysis  provided  as  precise  an  analysis
as  possible  of  the  behavior  of  the  lengthened  segment,  both
as  of  ﬁxator  ablation  and  over  the  long  term,  regardless  of
pubertal  status.
To  investigate  possible  growth-rate  change  after  length-
ening,  whether  stimulation,  transitory  slowing  of  growth
during  the  ﬁrst  year  or  deﬁnitive  cessation  of  growth,  the
following  index  was  calculated  at  end  of  growth  phase:
RGG (%) = PFSSD  − (LG ±  FRSD) × 100%
FLSL
where:  RGG  =  residual  growth  gain;  PFSSD  =  predicted  ﬁnal
spontaneous  segmental  discrepancy  (mm);  LG  =  length  gain
• growth-rate change; 2: long-term growth-rate change
.05).
chieved  by  external  ﬁxation  (mm);  FRSD  =  ﬁnal  residual
egmental  discrepancy  (mm:  healthy  segment  length  minus
engthened  segment  length);  and  FLSL  =  ﬁnal  lengthened
egment  length  (mm)  (Fig.  1).
This  index  represents  the  change  in  spontaneous  growth
fter  progressive  lengthening  with  respect  to  the  ﬁnal  length
f  the  lengthened  segment;  it  may  be  positive  (growth
timulation),  neutral  (no  change)  or  negative  (slowing  of
pontaneous  growth).
tatistical  methodology
hange  in  growth  rate  was  ﬁrst  assessed  over  the  short
nd  long  terms  (1  year  after  the  end  of  the  lengthening
rocedure  and  at  end  of  follow-up:  n  =  99),  and  then  in
erms  of  bone  maturity  (group  1,  before  full  maturity,  n  =  71;
nd  group  2,  after  full  maturity,  n  =  43).  Factors  potentially
ffecting  growth  rate  were  then  assessed:  age  at  proce-
ure,  percentage  lengthening  and  single  versus  multi-step
engthening.
Analysis  used  the  Student  t  test  for  independent  sam-
les,  on  StatPlus® Professional  (2008)  software,  with  the
igniﬁcance  threshold  set  at  P  <  0.05.
esults
hort-  and  long-term  growth  rates  both  showed  3  distinct
ehavior  patterns:  acceleration,  no  change,  and  slowing.
rocedures  were  therefore  grouped  ﬁrst  according  to  their
ssociated  short-term  growth  rate  pattern:  group  A,  with  no
lowing  down  of  growth  (i.e.,  either  transitory  acceleration
r  no  change),  and  group  B  with  slowed  growth:
 group  A  showed  no  short-term  slowing  of  growth,  followed
by  1  of  3  long-term  patterns:  acceleration  (I),  no  change
(II)  or  slowing  (III);
 group  B,  which  showed  slowing  of  growth  over  the  short
term,  then  showed  either  resumption  (I)  or  deﬁnitive  ces-
sation  (II)  of  growth  over  the  long  term.
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Figure  2  Representation  of  the  ﬁve  types  of  residual  segmen-
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Figs.  3  and  4  show  percentage  residual  growth  gain
according  to  age  at  initiation  of  1-step  lengthening  in  male
and  female  children.  The  results  show  that  initiation  before
the  age  of  12  years  in  boys  and  9  years  in  girls  was  asso-
ciated  with  long-term  stimulation  of  spontaneous  growth
(types  AI  and  AII,  corresponding  to  positive  RGG).  Initiation
immediately  after  the  onset  of  the  pubertal  growth  boost,
in  contrast,  was  associated  with  slowing  of  growth  and  thus
with  a  negative  RGG.  In  this  subgroup  of  1-step  lengthening,
the  greatest  reductions  in  RGG  were  found  in  case  of  initia-
tion  at  9—12  years  bone  age  in  girls  and  12—14  years  in  boys.
This  accounts  for  the  slowed  growth  associated  with  ﬁrst
lengthening  procedure  in  the  oldest  children  (types  AIII  and
BII).  We  suspect  that  the  negative  effect  is  greatest  when
the  lengthening  program  is  performed  during  the  lower-limb
pubertal  growth  boost,  although  this  boost  was  not  explicitly
assessed  in  the  present  study;  we  therefore  deﬁned  a  bone
age  interval  as  a  factor  meant  to  approximate  the  puber-
tal  phase,  during  which  lengthening  procedures  should  be
avoided.
These  results  were  also  found  on  analysis  of  groups  2  and
1  (having  reached  cessation  of  growth  or  not,  respectively,
at  the  time  of  study):  growth  was  signiﬁcantly  slowed  in
children  who  were  older  at  the  time  of  lengthening,  in  both
groups  1  and  2  (Tables  2  and  3);  i.e.,  slowed  growth  of  type
Figure  3  Residual  growth  gain  in  boys:  positive  in  lengthening
performed  before  12  years’  bone  age.al growth  following  progressive  bone  lengthening  for  congenital
ength  discrepancy.
Five  patterns  of  growth  rate  change  could  thus  be  distin-
uished  (Table  1  and  Fig.  2).  Types  AI  and  AII  are  associated
ith  good  prognosis  for  ﬁnal  residual  growth,  and  types  AIII,
I  and  BII  with  poor  prognosis:
 type  AI:  no  change  in  or  transitory  acceleration  of  initial
growth  rate  during  the  ﬁrst  year  after  EF  ablation,  with
acceleration  over  the  long  term;
 type  AII:  no  change  in  or  transitory  acceleration  of  initial
growth  rate  during  the  ﬁrst  year  after  EF  ablation,  with
growth  progressively  returning  to  its  pre-procedural  rate
over  the  long  term;
 type  AIII:  no  change  in  or  transitory  acceleration  of  ini-
tial  growth  rate  during  the  ﬁrst  year  after  EF  ablation,
followed  over  the  long  term  by  a  reduced  growth  rate,
falling  below  the  initial  pre-procedural  rate;
 type  BI:  slowing  or  transitory  cessation  of  during  the  ﬁrst
year  after  EF  ablation,  with  long-term  growth  recovering
or  even  exceeding  the  initial  pre-procedural  rate;
type  BII:  slowing  (or  cessation)  of  growth  during  the  ﬁrst
year  after  EF  ablation,  followed  over  the  long  term  by
continued  slowing  of  growth  until  deﬁnitive  cessation.
The  differences  between  these  ﬁve  types  were  statisti-
ally  signiﬁcant;  types  AI  and  AII  showed  positive  RGG  and
ypes  AIII,  BI  and  BII  showed  negative  RGG.
actors  impacting  growth  rate
ertain  factors  could  be  identiﬁed  as  affecting  the  various
esidual  growth  patterns  in  the  lengthened  segments.ge  at  initiation  of  lengthening
ge  at  initiation  of  lengthening  directly  impacted  growth
ates.
Figure  4  Residual  growth  gain  in  girls:  negative  in  lengthening
performed  after  9  years’  bone  age.
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Table  2  Distribution  of  results  according  to  long-term  change  in  growth  ratea in  patients  before  the  end  of  their  growth  phase
(group 1:  n  =  71).
Parameters  Long-term  change  in  lengthened  segment  growth  after  EF  ablation
Acceleration  No  change  Slowing
Number:  71  lengthenings  34  22  15
Age 7.1  ±  0.28AIII 7.2  ±  0.41AIII 8.4  ±  0.40
Length gain  (cm)  5.0  ±  0.24  4.6  ±  0.35  5.1  ±  0.48
% length  gain  21.7  ±  1.57  19.0  ±  2.37  22.2  ±  3.11
First lengthening  34  21  9
Iterative lengthening  0  1  6
Femoral HI 25.9  ±  2.06 24.8  ±  1.85 27.0  ±  3.0
Tibial HI 23.5  ±  1.37 21.8  ±  2.96 20.2  ±  2.05
Knee bridging 14  5  10
2 0.38  ±  0.05AII,  A  III 0.02  ±  0.01AIII −0.43  ±  0.07
FU 4.2  ±  0.43  4.5  ±  0.51  4.4  ±  0.54
a AII, AIII — Signiﬁcant difference between groups (P < 0.05).
Table  3  Distribution  of  results  according  to  long-term  change  in  growth  ratea in  patients  after  the  end  of  their  growth  phase
(group 2:  n  =  43).
Parameters  Long-term  change  in  lengthened  segment  growth  after  EF  ablation
Acceleration  Acceleration
Number:  43  lengthenings  9  14  20
Age 7.8  ±  0.57AII,  AIII 10  ±  0.4  11.4  ±  0.51
Length gain  (cm)  4.8  ±  0.34  4.7  ±  0.58  4.4  ±  0.48
% length  gain  25.9  ±  4.22  18.3  ±  3.32  13.6  ±  1.94
First lengthening  7  12  6
Iterative lengthening  2  2  14
Femoral HI  24.9  ±  2.31  22.8  ±  1.99  27.5  ±  3.26
Tibial HI  23.8  ±  4.82  34.4  ±  6.18  31  ±  3.39
% RGG  2.5  ±  0.35AII,  AIII 0.8  ±  0.39AIII −3.3  ±  0.87
Knee bridging  5  4  12
2 0.36  ±  0.081AII,  AIII 0.03  ±  0.015AIII −0.6  ±  0.05
FU 6.3  ±  0.44  5.3  ±  0.24  3.95  ±  0.41
n
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la AII, AIII — Signiﬁcant difference between groups (P < 0.05).
BI  or  BII  did  not  depend  on  the  child  having  reached  the  end
of  the  growth  phase.
Number  of  lengthening  procedures  per  segment
Stimulation  or  resumption  of  normal  growth  (types  AI  or  AII)
was  observed  in  most  cases  of  ﬁrst  lengthening:  57  out  of  60
(95%).
In  contrast,  in  both  femur  and  tibia,  iterative  lengthen-
ing  severely  impaired  residual  growth,  even  when  performed
outside  of  the  pubertal  growth  boost  period.  Signiﬁcant
slowing  followed  by  arrest  (type  BII)  was  observed  in  17
of  the  24  cases  of  iterative  lengthening  (70.8%),  indepen-
dently  of  end  of  growth:  in  both  groups  1  and  2,  slowing  of
growth  was  mainly  observed  in  cases  of  iterative  lengthening
(Tables  2  and  3).Interval  between  lengthening  procedures
Growth  disorder  was  mainly  associated  with  iterative  length-
ening  of  the  same  segment.  RGG  at  end  of  growth  was
i
a
begative  (−1.8%  to  −12.8%)  when  the  interval  between  pro-
edures  lay  between  1  and  3  years,  but  was  positive  when
he  second  lengthening  procedure  was  performed  before  the
ubertal  growth  boost  and  more  than  3  years  after  the  ﬁrst
rocedure.  Obviously,  no  slowing  effect  occurred  when  the
econd  lengthening  procedure  was  performed  toward  the
nd  of  the  growth  phase  (Fig.  5).
ercentage  lengthening
hen  the  percentage  lengthening  in  a  ﬁrst  procedure
xceeded  30%  of  initial  segment  length,  transitory  slowing
f  growth  was  observed  during  the  ﬁrst  year  after  the  proce-
ure,  followed  by  a  return  to  the  preoperative  growth  rate
type  BI):  i.e.,  negative  RGG  at  end  of  growth.  Percentage
engthening  of  less  than  30%,  however,  showed  no  signiﬁcant
mpact,  and  other  factors  must  therefore  be  implicated.
No  signiﬁcant  effects  on  residual  growth  rates  were
ssociated  with  external  osteosynthesis  duration  or  knee
ridging.
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than  8  years  at  time  of  procedure.  These  ﬁndings  are  inigure  5  Representation  of  residual  growth  gain  with  itera-
ive lengthening:  negative  for  intervals  less  or  equal  to  3  years.
iscussion
n  congenital  lower-limb  length  discrepancy,  lengthening
rocedures  often  need  to  be  performed  before  the  end  of
pontaneous  growth,  due  to  the  functional  and  psychological
mpact  of  the  discrepancy  on  child  and  family.  Prognosis  for
he  lengthened  segments  should  be  assessed  as  rigorously  as
ossible,  so  as  to  adapt  the  lengthening  strategy.
The  present  series  exclusively  included  congenital
athology,  making  it  homogeneous,  with  a  large  enough  sam-
le  in  terms  of  statistical  power  to  analyze  the  results.
cCarthy’s  et  al.  results  were  less  clear-cut,  but  his  series
f  discrepancies  involved  a  variety  of  etiologies,  which
ay  account  for  the  difference  in  results  [9].  As  congeni-
al  discrepancies  show  a  percentage  length  difference  that
emains  stable  over  growth  in  absence  of  treatment,  we
ccepted  the  hypothesis  that  any  observed  change  in  growth
attern  would  be  identical  across  all  congenital  etiologies,
ndependently  of  segment  location.
Growth  stimulation  following  a  ﬁrst  Ilizarov  lengthening
rocedure  was  systematic  when  bone  age  was  less  than  12
ears  in  boys  or  9  years  in  girls,  and  could  reach  1.1  to  4.7%
f  ﬁnal  lengthened  segment  length.
This  mechanism  may  be  explained  by  stimulation  due
o  increased  vascularization  during  lengthening,  or  by  a
echanical  cause  [5].  This  growth-stimulation  effect  was
escribed  in  fracture,  but  lasted  less  than  2  years  [16,17].
ome  reports  stressed  the  importance  of  having  a correct
iomechanical  axis  and  of  functional  loading  to  minimize
isturbance  of  conjunctive  cartilage  growth  over  periods
xceeding  2  years  [18,19].  Experimental  studies  showed
hat  cell  number  per  column  in  the  growth  area  depends
n  the  forces  acting  on  the  cartilage,  increasing  with
ncreased  loading.  The  greater  the  number  of  cells,  the
ore  active  the  cartilage  [20]. Antonov  demonstrated
he  growth-stimulating  effect  of  functional  forces  under
ynamic  loading  [18].
External  ﬁxation  allows  all  deformities  to  be  progres-
ively  corrected,  avoiding  impairment  of  joint  range  of
otion  during  lengthening  and  ensuring  a  perfect  biome-
hanical  axis  in  three  dimensions  [21—24]. Malformed  limbs
re  often  misaligned,  and  the  correction  site  is  often  epiphy-
eal,  metaphyseal  or  meta-diaphyseal.  Joint  bridging  avoids
a
e
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nducing  subluxation  and  hyperpressure  threatening  the  con-
unctive  cartilage.  External  ﬁxation  thus  ensures  optimal
onditions  for  resumed  growth,  correcting  conjunctive  car-
ilage  obliquity  and  producing  a  regular  distribution  of  force,
hereby  improving  lower-limb  function  in  stance  and  gait.
Oostenbroek  et  al.  recommended  bridging  the  knee
oint  and  maintaining  joint  distraction  force  throughout
he  period  of  external  osteosynthesis  in  order  to  obtain
ubsequent  growth  stimulation  [25]; they  did  not  specify,
owever,  whether  distraction  was  applied  throughout  the
engthening  process  in  their  series,  nor  did  they  measure  the
istraction  force  between  rings.  Pennec¸ot  et  al.  [2]  reported
 signiﬁcant  impact  on  the  growth  plate  after  progressive
one  lengthening  by  Judet  distractor.  The  harmful  effects  of
yperpressure  on  the  conjunctive  cartilage,  impaired  vascu-
arization  and  the  resultant  shaft  ischemia  may  account  for
ubsequent  slowing  of  growth.  However,  the  1—2  mm  ini-
ial  joint-line  distraction  reported  by  Pennec¸ot  et  al.  was
robably  insufﬁcient  to  prevent  contact  between  the  joint
urfaces  and  avoid  shaft  compression  [24]. In  the  present
eries,  there  was  no  signiﬁcant  difference  in  residual  growth
ate  associated  with  bridging  of  the  knee,  and  no  conclu-
ion  can  thus  be  drawn  as  to  whether  bridging,  performed
asically  to  avoid  joint  impairment,  also  protects  the  tibial
haft.
The  reduction  in  growth  observed,  however,  was  not  nec-
ssarily  related  to  the  hyperpressure  effects  described  by
he  above  authors.  Obtaining  and  maintaining  a  normal  axis
uring  the  lengthening  procedure  seems  to  us  to  be  a  neces-
ary  but  not  sufﬁcient  condition  for  growth  to  be  conserved;
ther  factors  are  involved  [23,24].
Percentage  lengthenings  emerged  as  one  of  the  main
actors  impacting  residual  growth.  An  experimental  study,
owever,  reported  that  a  lengthening  of  30%  did  not  affect
ongitudinal  tibial  growth  [26]; these  conclusions  were
rawn  from  morphological  results  at  only  5  weeks’  follow-
p.  Clinical  data,  in  contrast,  demonstrate  the  negative
mpact  of  such  a length  gain.  Viehweger  et  al.  [6],  in  series  of
4  children,  reported  a  clear  impact  on  residual  growth  fol-
owing  lengthening  exceeding  30%  using  a  unilateral  external
xator.  In  the  present  series,  this  result  corresponds  to  resid-
al  growth  types  BI  and  BII,  where  excessive  percentage
engthening  induces  slowed  growth  over  the  ﬁrst  year  fol-
owing  the  procedure.  It  can  reasonably  be  concluded  that
ingle-step  lengthening  of  more  than  30%  of  initial  segment
ength  is  to  be  avoided  in  congenital  lower-limb  length  dis-
repancy,  as  it  may  impair  resumption  of  growth.  In  the
resent  series,  percentage  lengthenings  less  than  30%  had
ery  little  impact  if  any  on  growth.  In  groups  BI  and  BII,
ther  factors  may  be  considered  to  have  had  much  more
armful  effect  (Tables  1—3).
Osseous  age  at  time  of  lengthening  is  a factor  to  be  taken
nto  account  in  treatment  planning  in  congenital  lower-limb
bnormality.  Pouliquen  et  al.  [3]  reported  that  lengthening
erformed  before  the  age  of  11  years  induced  growth  dis-
rder;  this  series,  however,  included  only  six  children  with
ongenital  discrepancy.  The  present  results,  on  the  contrary,
howed  greater  growth  stimulation  gain  in  children  aged  lessgreement  with  those  of  Suva  et  al.  [5],  who  reported  accel-
rated  growth  of  a  mean  2.5%  in  all  children  treated  at  less
han  6  years  of  age.
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[Analysis  of  segmental  residual  growth  after  progressive  bone
Other  authors  have  shown  that  lower-limb  lengthening
performed  just  after  the  start  of  the  pubertal  growth  boost
inevitably  slows  growth  in  the  operated  segment  [27]. This
is  conﬁrmed  by  the  present  ﬁndings:  lengthening  performed
after  the  start  of  the  pubertal  growth  boost  (here  taken  as
after  12  years’  bone  age  in  boys  and  10  in  girls,  due  to  the
impossibility  of  having  a  reliable  physiological  estimate  of
pubertal  maturity)  led  to  a  negative  RGG  and  all  the  more
so  in  the  early  phases  of  puberty.
The  exact  mechanism  of  slowed  growth  can  only  be
guessed  at.  During  the  intense  pubertal  spontaneous  growth
phase,  the  soft  tissue  of  the  lengthened  segment  cannot
adapt  to  the  change  in  length,  which  may  result  in  hyper-
pressure  on  the  growth  plate.  Suva  et  al.  [5]  suggest  a
phenomenon  of  growth  capital  exhaustion  to  account  for
slowing.
It  also  emerged  that  iterative  lengthening  of  the  affected
segment,  even  when  performed  before  the  pubertal  growth
boost  and  remaining  less  than  30%  of  initial  segment  length,
induced  negative  RGG  when  conducted  at  close  intervals  (of
less  than  3  years).  These  ﬁndings  may  guide  planning  length
equalization  when  the  discrepancy  prognosis  requires  iter-
ative  lengthening  [28]: iterative  lengthening  of  a  segment
should  be  undertaken  before  the  beginning  of  the  pubertal
growth  boost  but  more  than  3  years  after  the  ﬁrst  procedure.
The  alternative  is  to  perform  the  second  lengthening  around
the  end  of  spontaneous  growth.  This  program  can  thus  be
applied  to  manage  severe  femoral  or  tibial  hypoplasia.
In  the  light  of  these  results,  and  on  condition  that  the
principles  of  concomitant  correction  of  associated  deformi-
ties  are  respected  while  protecting  the  joint  by  bridging  if
necessary  to  avoid  or  limit  growth  plate  hyperpressure,  cer-
tain  favorable  factors  emerge  for  resumed  growth  in  the
lengthened  segment:
•  the  upper  bone  age  limit  for  initiating  lengthening  is  12
years  in  boys  and  9  years  in  girls;
• lengthening  should  be  systematically  associated  to  restor-
ing  the  mechanical  axis  of  the  lower  limb;
• any  second  lengthening  of  the  same  segment  should  be
performed  before  the  beginning  of  the  pubertal  growth
boost  but  more  than  3  years  after  the  ﬁrst,  or  else  around
the  end  of  spontaneous  growth.
Factors  liable  to  induce  slow  growth  are:
•  iterative  lengthening  less  than  3  years’  interval;
•  lengthening  performed  just  after  the  beginning  of  or  dur-
ing  the  pubertal  lower-limb  growth  boost;
•  length  gain  exceeding  30%  of  initial  segment  length.
Conclusion
It  is  fundamental  to  the  treatment  strategy  for  severe
congenital  deformity  and  length  discrepancy  to  respect  or
optimize  subsequent  resumption  of  growth  in  the  length-
ened  segment.  ‘‘Therapeutic’’  growth  stimulation,  as  found
in  trauma  cases,  is  here  an  illusion.  The  equalization  pro-
gram  should  take  account  of  the  factors  detailed  above  as
affecting  spontaneous  growth  in  the  lengthened  limb  in  case
of  congenital  discrepancy;  these  factors  may  be  somewhat
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ifferent  in  the  case  of  acquired  limb-length  discrepancy  or
f  the  upper  limbs.
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